Investor relief after AstraZeneca settles Seroquel case for £125m
AstraZeneca’s premises in Macclesfield, Cheshire. Photograph: Peter Byrne/PA AstraZeneca, the pharmaceutical group, has agreed to pay 8m (£125m) to US claimants to settle part of a dispute over its anti-psychosis drug, Seroquel. The deal, which follows a court-ordered mediation, covers...










